Huntington Bancshares Stock (NASDAQ: HBANM)

Huntington Bancshares (NASDAQ:HBANM) Stock, Quote.Headers.trade-ideas

Huntington Bancshares Inc is a regional bank holding company headquartered in Columbus, Ohio. The bank operates in two business segments: Consumer & Regional Banking and Commercial Banking. The bank derives the maximum of its revenue from the Consumer & Business Banking segment. The other segment of the bank consists of Treasury and others. The bank also provides auto dealer, equipment finance, investment management, trust, brokerage, capital market services, and other services.

Huntington Bancshares Incorporated - Depositary Shares each representing a 1/1000th interest in a share of Huntington Series I Preferred Stock

Huntington Bancshares Inc

Vice President Kamala Harris continues to lead over Donald Trump with two months to go until the <a href="https://www.benzinga.com/topic/2024-election">2024 presidential election.</a>
What Happened: Harris continues to see leads in head-to-head polls and maintains a lead in a key national poll ahead of Tuesday's <a href="https://www.benzinga.com/general/politics/24/09/40782598/harris-vs-trump-how-to-watch-2024-presidential-debate-rule-disputes-and-key-topics-for-voters">highly anticipated presidential debate </a>between the current vice president and the former president.
A new Morning Consult poll of likely voters show Harris' lead holding steady at three points ahead of the presidential debate.
The new <a href="https://pro.morningconsult.com/trackers/2024-presidential-election-polling?utm_source=briefing&amp;utm_medium=email&amp;utm_campaign=washington_am&amp;utm_content=091024">poll </a>shows the following results form voters, with the results from the<a href="https://www.benzinga.com/general/politics/24/09/40759548/harris-vs-trump-vice-president-on-top-by-three-points-how-her-lead-compares-to-the-2020-election"> Sept. 3 poll</a> in parentheses.
<ul>
<li>Kamala Harris: 49% (49%)</li>
<li>Donald Trump: 46% (46%)</li>
<li>Someone Else: 2% (2%)</li>
<li>Don't Know: 2% (3%)</li>
</ul>
The poll found that 94% of Democrats backed Harris as their top pick, up one percentage point from last week's poll. The poll also found that 91% of Republicans backed Trump as their top pick, which was in line with last week's poll.
Independent voters selected the following as their head-to-head preference, with the results from the Sept. 3 poll in parentheses:
<ul>
<li>Kamala Harris: 46% (47%)</li>
<li>Donald Trump: 40% (41%)</li>
<li>Someone Else: 6% (6%)</li>
<li>Don't Know: 7% (6%)</li>
</ul>
Harris maintained a six-point lead in the race for Independent voters, with both candidates losing one percentage point from the previous poll.
The vice president also has the edge in the 18-34 aged voters demographic leading 53% to 43%. The 10-point lead is significantly higher than a five-point advantage (50% to 45%) in last week's poll.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: The latest Morning Consult poll and the one before it has shifted to include only the results of likely voters and not all registered voters. This could provide one of the better illustrations of what could happen in November.
Harris continues to rank ahead of Trump in the weekly head-to-head poll, maintaining a lead each week since the head-to-head update in the poll took place with President Joe Biden stepping down in the 2024 election.
Harris' lead is smaller than one that Biden had against Trump at this stage in the 2020 election. With two months to go before the 2020 election, Biden led Trump by eight percentage points among likely voters 51% to 43%.
This suggests that this year's presidential election could be closer than in past years.
The latest Morning Consult poll found that Harris' popularity has declined among likely voters. The vice president's net favorability is only one point, with voters only one point more likely to hold favorable opinions of Harris than those who hold unfavorable opinions (50% to 49%). For comparison, Trump's net favorability is negative 10 points with more likely voters having an unfavorable opinion than favorable one.
Morning Consult released the results of likely voters<a href="https://www.benzinga.com/topic/swing-states"> in swing states </a>and several other states expected to be close. Here are the current <a href="https://pro.morningconsult.com/trackers/2024-election-state-polls?utm_source=briefing&amp;utm_medium=email&amp;utm_campaign=washington_am&amp;utm_content=091024">results</a>:
Arizona: 47% Harris, 49% Trump
Georgia: 48% Harris, 48% Trump
Michigan: 49% Harris, 46% Trump
Nevada: 48% Harris, 48% Trump
North Carolina: 48% Harris, 48% Trump
Pennsylvania: 49% Harris, 46% Trump
Wisconsin: 49% Harris, 46% Trump
In the key seven swing states, Harris leads in three states, Trump leads in one state and the two candidates are tied in three states.
The poll that follows next week could be one of the most closely watched as it will consider the answers from likely voters after Harris and Trump faced off for the first time in Tuesday's presidential debate.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Shutterstock

Politics

Harris Vs. Trump: Vice President Holds 3-Point Lead Ahead Of Presidential Debate, But Swing States Still Close, Up For Grabs

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)&nbsp;CEO Brian Moynihan <a href="https://www.benzinga.com/markets/equities/24/09/40792082/whats-going-on-with-bank-of-america-stock-on-tuesday">praised Warren Buffett</a> on Tuesday as an investor in the company, but said he has not asked the legendary investor why he has lowered his position in Bank of America.
&#8220;He has been a great investor for our company, stabilized our company,&#8221; Moynihan said about Buffett during an investor conference in New York, Reuters reported. &#8220;I don&#8217;t know what exactly he is doing because frankly we can&#8217;t ask.&#8221;
Buffett&#8217;s Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) the biggest shareholder in BofA,&nbsp;has been reducing its stake in the U.S. bank, making total share sales since mid-July of nearly $7 billion.
Berkshire&#8217;s stake in Bank of America stands at about 11.1%, according to LSEG data.
Read Also: <a href="https://www.benzinga.com/general/education/24/09/40795866/warren-buffetts-sister-lost-every-game-of-monopoly-all-my-money-was-gone-but-she-says-she-train">Warren Buffett&#8217;s Sister Lost Every Game Of Monopoly — &#8216;All My Money Was Gone,&#8217; But She Says She &#8216;Trained Him To Be A Winner&#8217;</a>
Moynihan also discussed the proposed changes in capital rules after the Federal Reserve Chairman Jerome Powell laid out a plan on Tuesday to raise big bank capital by 9%, significantly reducing an earlier proposal after intense Wall Street pushback.
Moynihan said the proposed changes are manageable for Bank of America, and it will keep buying back stock, but warned that higher capital requirements for large banks could reduce lending.
&#8220;If our capital goes up by 10%, it stops us from making $160 billion (in) loans we would otherwise make. Those loans would go to small businesses and middle-market companies at competitive rates,&#8221; he said.
Speaking about performance in the third quarter, he said investment banking revenue could be around $1.2 billion, a slight uptick from $1.18 billion in revenue posted in the same quarter a year earlier.
BAC Price Action: Bank of America fell 0.48% to close at $39.28 on Tuesday.
Exchange-traded funds that hold the stock also trended downward.
<ul>
<li>First Trust Nasdaq Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXO#NASDAQ">FTXO</a>) fell 1.71%</li>
<li>Invesco KBW Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBWB#NASDAQ">KBWB</a>) slipped 1.83%</li>
<li>IShares U.S. Financial Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>) declined 1.11%</li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40750695/warren-buffett-trims-bank-of-america-stake-analysts-speculate-why">Warren Buffett Trims Bank Of America Stake, Analysts Speculate Why</a></li>
</ul>
Photo: Brian Moynihan, Bank of America at World Economic Forum (WEF), Courtesy WEF via <a href="https://www.flickr.com/photos/worldeconomicforum/52095722888/in/photolist-2nnwcqL-RdLSNL-RdLSFm-2nnw5nq-SrPEcd-RgrMo6-7z8ezp-E4BHQD-RdLSMU-RdLSyN-2nnwcc4-SrPEbw-RdLSKE-SrPEd5-2nnV7BY-RgrMka-brGbFG-Svu93D-2nnwcb2-SrPEbb-SrPE9h-2nnNBgZ-SrPEau-RdLSPC-nAFmrs-aZcfDv-R8p38P-2nnV7AL-2bXeSgX-2nnwc1h-brHePm-2nnwbW9-2bXeW4g-2nnxi6n-2bXeZA6-2kwL7x3-2nxZQGK-brKH3j-2nsCzDU-JLFmTp-2jF3WQC-aUGnoR-22CQiXy-6JF8ms-2nsDn2n-E4vGw8-2nWZRuR-bDD5W1-bDD6uo-2nX1NAZ">Flickr</a> Creative Commons

News

Federal Reserve

ETFs

FTXO

iShares Trust Dow Jones US Financial Services Index Fund

KBWB

Bank Of America CEO On Buffett's Share Retreat: 'I Don't Know What Exactly He Is Doing ... We Can't Ask'

Missouri Governor Mike Parson and Attorney General Andrew Bailey <a href="https://governor.mo.gov/press-releases/archive/governor-parson-attorney-general-bailey-announce-new-actions-combat-spread">announced</a> new actions to regulate psychoactive cannabis products in the state.
Their decision follows California's <a href="https://www.benzinga.com/markets/cannabis/24/09/40761471/cheech-and-chongs-cannabis-company-responds-to-gov-newsoms-ban-on-hemp-products-containing-any-d">crackdown on hemp</a>, led by Governor Gavin Newsom, which has sparked concern among industry leaders. 
Missouri&#8217;s new actions to combat unregulated cannabis, introduced through a joint task force between the Attorney General's Office (AGO) and the Division of Alcohol and Tobacco Control (ATC) aim to combat the spread of unregulated psychoactive hemp products.
Governor Parson echoed a familiar argument citing the protection of children as a primary reason for the crackdown. 
&#8220;Together, with the help of the Attorney General and his team, we will root out these cannabis products being deceptively marketed to our children until such time the General Assembly provides the statutory framework for commonsense regulations,&#8221; Parson said in a press conference.
<h3 class="wp-block-heading">&#8216;Protect The Children&#8217;</h3>
&#8220;We are building on our existing investigation into these harmful, illicit products by formalizing a unit within my Consumer Protection Division that will be dedicated to investigating referrals from the ATC&#8221; said Attorney General Bailey. &#8220;We will enforce the law to protect our children every step of the way."
The AGO and ATC will form a joint task force. Under this partnership, the ATC will investigate its licensees selling unregulated psychoactive cannabis products, collect evidence of deceptive marketing and refer cases to the AGO. In response, the AGO will create a specialized unit within its Consumer Protection division to review these referrals.
This unit will use the Missouri Merchandising Practices Act (MMPA) to take legal action against licensees engaging in prohibited practices related to psychoactive cannabis products.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Missouri Hemp And Cannabis Battle Intensifies</h3>
Missouri&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/09/40740888/missouris-hemp-battle-heats-up-as-governor-parson-revives-ban-in-a-mark-twain-like-drama">recent crackdown</a> on intoxicating hemp products adds further weight to the state&#8217;s aggressive approach toward <a href="https://www.benzinga.com/markets/cannabis/24/08/40323184/missouri-governors-thc-ban-threatens-9-000-retailers-statewide-amid-nationwide-clampdown-on-hemp">regulating cannabis derivatives</a>.
Parson recently ordered the removal of &#8220;adulterated&#8221; hemp products, citing again significant rise in cannabis poisoning cases among children as a key driver behind the regulations. Parson's actions mirror <a href="https://www.benzinga.com/markets/cannabis/24/09/40756333/gov-newsom-proposes-emergency-rules-to-severely-restrict-hemp-products-this-will-destroy-our-bus">those in</a> <a href="https://www.benzinga.com/markets/cannabis/24/09/40756333/gov-newsom-proposes-emergency-rules-to-severely-restrict-hemp-products-this-will-destroy-our-bus">California</a>, targeting psychoactive compounds like delta-8 THC under the banner of child safety.
The move has sparked outrage from industry leaders and legal pushback from groups like the Missouri Hemp Trade Association. The group argues that the regulations threaten small businesses and limit consumer access to legal products. 
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/09/40740888/missouris-hemp-battle-heats-up-as-governor-parson-revives-ban-in-a-mark-twain-like-drama"> Missouri&#8217;s Hemp Battle Heats Up As Governor Parson Revives Ban In A Mark Twain-Like Drama</a>
<h3 class="wp-block-heading">Unregulated Cannabis: Nationwide Dispute</h3>
With the hemp industry increasingly in the crossfire, the state&#8217;s enforcement measures are expected to have serious implications for businesses as they struggle to adapt to the<a href="https://www.benzinga.com/markets/cannabis/24/07/39690898/no-more-getting-high-on-hemp-in-america-multiple-states-begin-intoxicating-hemp-crackdown"> evolving regulatory landscape.</a> 
Meanwhile, the Missouri Department of Health and Senior Services (DHSS) will continue to embargo unregulated psychoactive cannabis food products that don&#8217;t meet state and federal requirements. Since September 1, DHSS has inspected 64 facilities and found 39 locations with unregulated cannabis products on shelves. To date, 8,929 products have been embargoed through these actions, the Office of the Governor says.
These regulations come after California's Governor Gavin Newsom emergency measures banning THC in hemp products, which have <a href="https://www.benzinga.com/markets/cannabis/24/09/40761471/cheech-and-chongs-cannabis-company-responds-to-gov-newsoms-ban-on-hemp-products-containing-any-d">prompted an outcry </a>from industry stakeholders and praised <a href="https://www.benzinga.com/markets/cannabis/24/09/40799483/beer-industry-trade-association-endorses-california-governors-ban-on-hemp-derived-thc">by the beer industry</a>. 
Hemp leaders argue that such regulations will severely hurt small businesses and limit consumer access to legal, non-intoxicating products. 
Missouri's decision to double these efforts is likely to have significant consequences for the industry.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/09/40756333/gov-newsom-proposes-emergency-rules-to-severely-restrict-hemp-products-this-will-destroy-our-bus"> Gov. Newsom&#8217;s Total Ban On Hemp THC Could Crush California&#8217;s Billion-Dollar Industry, Say Stakeholders (UPDATED)</a></li>
</ul>
Photo: Courtesy of Office of Governor Michael L. Parson

Cannabis

Government

Regulations

Retail Sales

Markets

Missouri Joins Crackdown On Unregulated Cannabis, Announces New Taskforce As National Hemp Debate Rages

Car velocity, train speed and dwell have all recovered, and the Company is now essentially current with demand.
CN is revising its 2024 full year financial&nbsp;guidance.&nbsp;The quarter-to-date additional impact of labor uncertainty and the work stoppage, as well as the wildfires in Alberta, is estimated at around&nbsp;$0.20&nbsp;of EPS.
CN now expects to deliver adjusted diluted EPS growth in the low single-digit range, compared to its July 23, 2024, expectation of mid to high single-digit growth.
In light of updated expectations for 2024, and a weaker than expected economic environment, CN is replacing all its current financial&nbsp;outlook&nbsp;for the 2024-2026 period with the following: CN is now targeting compounded annual adjusted diluted EPS growth in the high single digit range.
&nbsp;

Guidance

CN Says Its Operations Have Recovered Following Several Months Of Labor Uncertainty; Adjusts Its 2024 Guidance And Long-Term Financial Outlook

A coalition of cannabis advocates is ramping up pressure on President Joe Biden to act on his promise of <a href="https://www.benzinga.com/markets/cannabis/24/06/39319868/meet-the-man-who-did-prison-time-for-non-violent-cannabis-offense-and-now-advocates-for-others-i">cannabis justice. </a>
On Tuesday, the Last Prisoner Project (LPP) and several partner organizations announced the Countdown for Clemency campaign, urging Biden to grant clemency to nearly 3,000 individuals still incarcerated for federal marijuana offenses, Marijuana Moment <a href="https://www.marijuanamoment.net/marijuana-reform-advocates-launch-countdown-to-clemency-campaign-pressing-biden-to-free-cannabis-prisoners-before-his-term-ends/">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38412810/president-biden-pardons-commutes-16-non-violent-drug-offenders-cannabis-prisoners-excluded">President Biden Pardons, Commutes 16 Non-Violent Drug Offenders: Cannabis Prisoners Excluded</a>
<h3 class="wp-block-heading">Activists Call For Broader Action</h3>
Despite Biden&#8217;s past efforts, which included pardoning thousands of people with federal cannabis possession convictions, no one has been released from prison as a result. 
The new campaign is pushing the president to use his clemency powers to right this wrong. "Time is running out on President Biden's term, but it is not too late for him to undo the harms inflicted on families impacted by cannabis criminalization," said Sarah Gersten, executive director of LPP.
The campaign's website features a large countdown clock, symbolizing the dwindling time before Biden's term ends. While Biden's pardons have helped people clear their records, the administration has not commuted the sentences of those still behind bars for cannabis-related offenses.
Recent polls show that Americans overwhelmingly support clemency for those incarcerated for marijuana offenses, now legal in many states. 84% of voters support releasing people serving time for cannabis crimes, while 72% approve of Biden's previous pardons for non-violent possession convictions.
<h3 class="wp-block-heading">Congressional Push Adds Weight</h3>
The campaign for clemency has gained momentum in Congress, where 36 lawmakers wrote to Biden in March, urging him to commute the sentences of non-violent cannabis offenders. 
Biden, however, has maintained a cautious stance. At a Wisconsin campaign stop earlier this year, he expressed his support for rescheduling marijuana but drew a distinction between users and dealers. "If you're out selling it, if you're out growing, it's a different deal," Biden said.
<h3 class="wp-block-heading">The Clock Is Ticking As November Elections Loom</h3>
With the 2024 election approaching, the administration appears aware of the growing public demand for cannabis reform. 
Both Biden and Vice President Kamala Harris have emphasized their efforts to address the issue, including a carefully timed announcement on April 20, a significant date in cannabis culture.
Harris has also publicly called on the Drug Enforcement Administration (DEA) to speed up its review of marijuana's classification under federal law.
With only months left in Biden&#8217;s presidency, the clock is ticking for thousands of individuals still serving time for cannabis offenses.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39998398/kamala-harris-admits-i-inhaled-marijuana-and-now-pushes-for-legalization-what-this-means-for-202">Kamala Harris Admits &#8216;I Inhaled&#8217; Marijuana And Now Pushes For Legalization: What This Means For 2024 Elections</a></li>
</ul>

Legal

Biden Faces Pressure To Release Thousands Imprisoned For Federal Cannabis Convictions

SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) announced on Tuesday that Taranvir &#8220;Tank&#8221; Vander, president of its Liquor Division, is stepping down after two decades of leadership in the liquor industry. Vander, who began his career as a liquor store manager in the early 2000s, is retiring to pursue new opportunities.
In 2013, Vander founded Ace Liquor Corporation, expanding it to 15 stores. In 2019, he joined forces with Alcanna Inc., helping it become one of Canada's largest liquor retailers. Zachary George, CEO of SNDL, thanked Vander for his contributions. "We want to thank Tank for his exceptional leadership and wish him continued success in his future endeavors."
Navroop Sandhawalia, VP of finance for Liquor Retail at SNDL, <a href="https://www.prnewswire.com/news-releases/sndl-announces-departure-of-liquor-segment-president-302244048.html#:~:text=CALGARY%2C%20AB%2C%20Sept.%2010,SNDL%20to%20pursue%20new%20opportunities">will take over</a> as interim president of the liquor division while the company searches for a permanent replacement.
Get Benzinga&#8217;s exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">SNDL Stock Performance Compared To Other Canadian Cannabis Companies</h3>
After the market closed on Tuesday, September 10, 2024, SNDL experienced a slight dip in its stock price, closing at $2.10, down 0.47%. Trading volume for SNDL reached 1,697,281 shares, reflecting continued investor activity as the company transitions leadership in its Liquor Division.
In comparison, other notable <a href="https://www.benzinga.com/topic/canada-cannabis">Canadian cannabis stocks</a> also saw mixed results:
<ul>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) closed at $5.55, down 1.56%, with 568,615 shares traded. Despite a lower percentage drop than SNDL, Aurora's stock showed greater volatility with a day high of $5.90 and a low of $5.55.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) fared slightly better, closing at $1.83, up 1.1%. The stock saw a trading volume of 297,194 shares, indicating moderate investor interest.</li>
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) closed at $1.69, down 0.59%, with a significant trading volume of 18,592,650 shares, reflecting heightened activity compared to other stocks.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) showed positive momentum, increasing by 3.3% to close at $2.13, with 447,671 shares traded, positioning it among the stronger performers in the sector today.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) closed at $4.84, down 1.03%, with a volume of 2,777,417 shares. Despite the decline, Canopy saw considerable trading activity, suggesting continued investor engagement.</li>
</ul>
Overall, <a href="https://www.benzinga.com/markets/cannabis/24/08/40631613/sndl-wins-bid-for-indiva-secures-major-deal-to-boost-cannabis-edibles-market-share-in-canada">SNDL's performance </a>was relatively stable compared to its peers, with many Canadian cannabis stocks experiencing minor fluctuations throughout the trading day. The trading volumes across the sector reflected ongoing interest but no significant market shifts following the day&#8217;s developments.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40783919/cannabis-flower-no-thanks-canadians-shift-to-pre-rolls-vapes-as-market-eyes-c-5-47b">Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls &amp; Vapes As Market Eyes C$5.47B</a>

Management

 CGC

HITI

SNDL

TLRY

Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes

The Company intends to use the net proceeds of the Offering to repay all of its outstanding borrowings under its term loan A facility, to pay fees and expenses in connection with the Offering, and for general corporate purposes.

Offerings

PHIN

PHINIA Reports Pricing Of Upsized Private Offering of $450M Of Senior Notes Due 2032

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 10.88% on an annualized basis producing an average annual return of 22.37%. Currently, Copart has a market capitalization of $47.64 billion. 
Buying $1000 In CPRT: If an investor had bought $1000 of CPRT stock 15 years ago, it would be worth $21,197.75 today based on a price of $49.51 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726003821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

$1000 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today

Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) has outperformed the market over the past 5 years by 10.72% on an annualized basis producing an average annual return of 23.55%. Currently, Brown &amp; Brown has a market capitalization of $29.42 billion. 
Buying $1000 In BRO: If an investor had bought $1000 of BRO stock 5 years ago, it would be worth $2,866.31 today based on a price of $103.13 for BRO at the time of writing.
<h3>Brown &amp; Brown's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726003816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Brown & Brown 5 Years Ago Would Be Worth This Much Today

This represents a&nbsp;$200 million&nbsp;increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. The closing of the offering of the Notes is expected to occur on September 13, 2024, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.

Avis Budget Subsidiaries Prices Private Offering Of $700M Of 8.250% Senior Notes Due 2030

Barnes &amp; Noble Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) reported its first-quarter financial results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/09/g40804179/barnes-noble-education-reports-first-quarter-fiscal-year-2025-financial-results">details from the report.&nbsp;</a>
The Details: Barnes &amp; Noble Education reported quarterly sales of $263.4 million, which missed the analyst consensus estimate of $268.321 million by 1.83% and is a 0.29% from the same period last year. The company said it is a highly seasonal business, and the first quarter is historically a period of low sales activity for the company.
The decrease in quarterly revenue was primarily driven by a net decrease in physical locations, many of which were closures of underperforming stores, the company said. Revenues from BNC First Day programs increased approximately $19.6 million, or 32%, helping to offset much of the decline.
Read Next: <a href="https://www.benzinga.com/news/24/09/40799508/whats-going-on-with-apple-stock-following-iphone-16-release">What&#8217;s Going On With Apple Stock Following iPhone 16 Release?</a>
&#8220;It was a very busy quarter as we completed our milestone equity and refinancing transactions and worked hard to prepare for the upcoming Fall Rush with our store teams, vendors and other business partners. We are excited by the momentum and fresh energy as we enter the new academic year,&#8221; said Jonathan Shar, CEO of Barnes &amp; Noble Education. 
Outlook: The company anticipates spending approximately $20 million on capital expenditures in fiscal year 2025, with the bulk of those investments focused on store improvements and technology. Barnes &amp; Noble Education did not provide formal guidance, but said &#8220;management&#8217;s budget goals target a material improvement in fiscal year 2025 GAAP operating results and Adjusted EBITDA versus last year.&#8221; 
BNED Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Barnes &amp; Noble Education shares are down 5.13% after-hours at $10.27 after dropping 5% in regular trading Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40799524/lucid-showcases-new-gravity-suv-teases-affordable-crossover-ev">Lucid Showcases New Gravity SUV, Teases Affordable Crossover EV</a></li>
</ul>
Photo: Mediamodifier from Pixabay

Earnings

Entertainment

Education

Movers

BNED

Barnes & Noble Education Stock Slips Following Q1 Results

The study, which included 40 patients, showed that prophylaxis with 8-mg dexamethasone taken for two days prior to the first infusion met the primary endpoint of incidence of IRRs at Cycle 1 Day 1 (C1D1), with an all-grades IRR rate for IV RYBREVANT&reg;&nbsp;of&nbsp;22.5 percent.
This represents a three-fold reduction in the incidence of IRRs compared to standard management of IRRs with IV RYBREVANT&reg;, where historic data has observed an all-grades incidence rate of&nbsp;67.4 percent.

Johnson & Johnson Says Dexamethasone Reduces Infusion-Related Reactions In Patients With EGFR-Mutated Non-Small Cell Lung Cancer Treated With Intravenous RYBREVANT

The cash dividend is payable on September 27, 2024 to shareholders of record as of September 20, 2024.

Dividends

First American Financial Boosts Quarterly Cash Dividend By 2% From $0.53 To $0.54 Per Share

Vice President Kamala Harris has gained endorsements from many politicians, business leaders and members of Hollywood, with singers including Beyonce throwing support her way with the <a href="https://www.benzinga.com/general/entertainment/24/08/40168992/beyonc-to-donate-4m-to-harris-in-bid-against-trump-she-feels-the-stakes-are-too-high">use of her songs.</a>
Global superstar Taylor Swift is believed to be a supporter of the Democratic Party and previously backed the Biden/Harris campaign, but has yet to show public support for Harris. Could that change in the final two months?
What Happened: There were reports that Beyonce or Swift <a href="https://www.benzinga.com/general/politics/24/08/40429245/2024-dnc-preview-democrats-to-rally-around-harris-walz-with-biden-obamas-clintons-and-more-will-">would be a surprise guest</a> at the 2024 Democratic National Convention, but the claims proved to be false.
Swift, who has been backing Democratic Party candidates in recent years, has yet to make an endorsement for the 2024 presidential election.
The musician previously backed a Democratic candidate for Senate in Tennessee in the 2018 election, as reported by <a href="https://variety.com/2024/music/opinion/taylor-swift-kamala-harris-1236138123/">Variety</a>. The endorsement was Swift&#8217;s first time speaking out on political matters.
Swift backed Joe Biden and running mate Harris in the 2020 election.
A potential endorsement of Harris could be a major turning point in the 2024 election, with Swift's celebrity status among the biggest figures globally and a huge reach among females and young voters.
Swift's political endorsements were previously covered in the 2020 Netflix documentary "Miss Americana" where the singer told her father that she needed "to be on the right side of history" by speaking out politically despite him opposing this. Swift also mentioned that she wishes she would have spoken up in the 2016 election previously.
The singer's quietness about the 2024 election also comes with Republican candidate Donald Trump using fake AI-generated images alleging Swift and her fans had endorsed him. Swift did not make a statement on the images.
Some Swift fans that support Harris and the Democratic Party are also critical of her friendship with Brittany Mahomes, wife of Kansas City Chiefs star Patrick Mahomes. Brittany Mahomes has been a vocal supporter of Trump and even drew a thank you from the former president for her support. Swift and boyfriend Travis Kelce, also of the Chiefs, have often been seen with the Mahomes duo.
Another reason Swift may not be speaking out on her political leanings could be fear of repercussions. A terrorist attack plan on Swift's concert in Vienna was stopped before the show, which was ultimately cancelled. Swift made a brief statement on the event.
"Let me be very clear: I am not going to speak about something publicly if I think doing so might provoke those who would want to harm the fans who come to my shows," Swift said.
The Variety article suggests that Swift may have more at stake now, given her global superstardom is far greater than it was when she previously endorsed political candidates.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: An endorsement from Swift is still a possibility, as she backed Biden in October 2020, a month before the election.
On prediction market Polymarket, over $409,000 has been bet on the market of whether Swift will endorse Harris before the 2024 election. The market leans to yes for an official endorsement coming before Nov. 4 at 76% as of<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40791846/taylor-swift-to-endorse-kamala-harris-77-chance-is-free-money-from-delusional-republicans-"> the time of writing.</a>
While the majority still believe she will endorse Harris, this figure has dropped from 88% in mid-August and 92% at the beginning of the month.
While Swift may not be publicly endorsing a candidate, that hasn't stopped her fans who are commonly known as Swifties from speaking out and<a href="https://www.benzinga.com/general/entertainment/24/08/40603751/taylor-swift-fans-raise-100k-for-kamala-harris-original-cat-lady-carole-king-elizabeth-warr"> raising money for the vice president.</a>
A "Swifties for Kamala Rally" took place recently and featured guest appearances from legendary songwriter and singer Carole King and Senator Elizabeth Warren (D-Mass.). The group raised over $100,000 in donations for Harris' 2024 election campaign.
In September, on National Voter Registration Day, Swift posted to her Instagram stories encouraging her fans to register to vote.
"I've been so lucky to see so many of you guys at my U.S. shows recently. I've heard you raise your voices, and I know how powerful they are. Make sure you're ready to use them in our elections this year!" Swift said, as shared by&nbsp;<a href="https://www.npr.org/2023/09/22/1201183160/taylor-swift-instagram-voter-registration" target="_blank" rel="noreferrer noopener">NPR</a>.
Swift's post was non-partisan and included a link to the voter registration at Vote.org.
A total of 35,252 people registered to vote during the 2023 National Voter Registration Day, marking the highest turnout since 2020. This figure represents a 23% increase from the previous year. Additionally, the number of 18-year-old voters doubled compared to 2022 during the 2023 campaign.
It&#8217;s unknown how many of the registrations Swift was directly responsible for. But the Vote.org website saw a 1,226% jump in site visits in the hour after Swift's Instagram story.
A potential Swift endorsement could be a key event in the 2024 election.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/06/39346067/donald-trump-shakes-off-potential-taylor-swift-endorsement-for-joe-biden-why-would-she-endo">Donald Trump Shakes Off Potential Taylor Swift Endorsement For Joe Biden: &#8216;Why Would She Endorse This Dope&#8217;</a></li>
</ul>
Photo: Shutterstock

Taylor Swift Endorsed Biden And Harris In 2020 — Will She Back Vice President Again In Final Stretch Of 2024 Election?

The British Cannabis Industry Council (CIC) issued a new report reminding housing providers in the UK of their obligations under the Equality Act 2010, which prohibits discrimination based on various disabilities.
The report, <a href="https://www.cicouncil.org.uk/app/uploads/2024/09/FINAL_CIC24_08-The-Use-of-Prescription-Cannabis-in-Buildings-1.pdf" target="_blank" rel="noreferrer noopener">The Use of Prescription Cannabis in Buildings</a> insists that landlords, property managers and housing associations must allow the use of prescribed medical marijuana within the confines of a tenant's private space and ensure privacy and confidentiality.
Any restrictions on the possession and consumption of prescribed medical cannabis is considered a discrimination and violates the Equality Act. Breaching the Act this way could lead to housing providers being taken to court or added to a &#8216;rogue&#8217; landlord database.
"Housing providers must treat prescription cannabis patients like any other medical patients, and indeed should take steps to ensure patients can consume their medication at home," stated the report author Mohammad Wasway of PatientsCann. "We urge landlords and housing associations to proactively engage with tenants and leaseholders, to ensure that do not discriminate against patients with disabilities."
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
The paper, reviewed by lawyer Robert Jappie, also provides guidance for patients regarding their legal rights.
"The Cannabis Industry Council will be engaging with housing providers to help them understand their legal obligations and support their tenants and leaseholders," said CIC Standards Working Group chair Elisabetta Faenza in a statement. "We believe it would be proportionate for landlords who continue to deny patients their basic rights to be added to ‘rogue' landlord databases or indeed be taken to court."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39651496/will-uk-cannabis-laws-change-under-new-labour-government-doesnt-look-that-way-just-yet">Will UK Cannabis Laws Change Under New Labour Government? Doesn&#8217;t Look That Way Just Yet</a>
<h2 class="wp-block-heading">Medical Marijuana In The UK</h2>
The need for cannabis as medicine was highlighted by two cases involving children with severe epilepsy. One is&nbsp;Billy Caldwell&nbsp;and the other is&nbsp;Alfie Dingley.&nbsp;They were both&nbsp;using cannabis low-dose THC&nbsp;oil&nbsp;to treat their seizures. Thanks to them and their families the need for cannabis as medicine was brought to the public, and the UK decided to embrace it in 2018.
Since then, the number of medical marijuana patients grew significantly. : &#8220;In July, Mamedica, a medical marijuana clinic in Westminster, <a href="https://www.bbc.com/news/articles/crgkxv6ljp4o" target="_blank" rel="noreferrer noopener">told </a>the BBC that patient numbers grew more than tenfold in 2023, from 250 to 2,750.
CEO Jon Robson said this was down to a &#8220;large number of patients who are transitioning to us not just from the illicit market, but because they haven&#8217;t found the treatments that the NHS can provide to be sufficient for their conditions&#8221;.
While it is possible to access medical marijuana through the National Health Service (NHS), this rarely occurs and only in severe cases of epilepsy, chemotherapy-induced nausea or certain cases of muscle stiffness associated with multiple sclerosis (MS). Since medical marijuana is not widely available via&nbsp;the NHS, many families struggle to&nbsp;<a href="https://www.benzinga.com/markets/cannabis/23/10/35388605/europes-high-uk-parents-need-nhs-help-for-daughters-seizures-thc-mmj-flowers-in-switzerland-more" target="_blank" rel="noreferrer noopener">afford life-saving medicine for</a> their children.
Read Next :
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/06/32693057/uk-moms-concern-as-no-doctor-will-prescribe-cannabis-for-her-daughters-300-daily-seizures">UK Mom&#8217;s Concern As No Doctor Will Prescribe Cannabis For Her Daughter&#8217;s 300 Daily Seizures</a></li>
</ul>
Photo generated with AI

Eurozone

British Landlords Must Allow Medical Marijuana Consumption And Ensure Privacy, Per New Report

Mark Sutton, who has continued to serve in the role of Chairman of the Board since retiring as CEO in May, will retire from the Board on&nbsp;September 30, 2024.

International Paper Names Andy Silvernail As Chairman In Addition To His Role As CEO, Effective October 1, 2024; Mark Sutton To Retire From Board

Leonardo DRS Delivers, Ahead Of Schedule, Critical C5I Capabilities For The Australian Army's Heavy Armoured Capability Systems

Kosmos Energy Reports Pricing Of $500M Of Its 8.750% Senior Notes Due 2031

Advanced Environmental Recycling Technologies

AERT

Aeries Technology Receives Deficiency Notification Letter From Listing Qualifications Staff Of Nasdaq

During the last three months, 6 analysts shared their evaluations of AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $94.33, with a high estimate of $108.00 and a low estimate of $66.00. This current average reflects an increase of 3.47% from the previous average price target of $91.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1726002021_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of AppLovin by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Heaney</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$108.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Mark Zgutowicz</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Sell</td>
<td>$66.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Nick McKay</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Nick McKay</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$97.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to AppLovin. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AppLovin compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of AppLovin's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into AppLovin's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/APP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on AppLovin analyst ratings.</a>
<h2>All You Need to Know About AppLovin</h2>
AppLovin Corp is a mobile app technology company. It focuses on growing the mobile app ecosystem by enabling the success of mobile app developers. The company's software solutions provide tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their applications.
<h3>Financial Insights: AppLovin</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: AppLovin's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 43.98%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: AppLovin's net margin excels beyond industry benchmarks, reaching 28.69%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): AppLovin's ROE stands out, surpassing industry averages. With an impressive ROE of 39.35%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AppLovin's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.88% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: AppLovin's debt-to-equity ratio is notably higher than the industry average. With a ratio of 4.32, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Huntington Bancshares

Huntington Bancshares (HBANM) Forecast

Huntington Bancshares (NASDAQ:HBANM) Stock, Quote.Headers.trade-ideas